YICHANG, China, Sept. 2, 2021 - Angel Yeast Co., Ltd ("Angel Yeast" or "Angel"), a listed high-tech yeast company in China, announced its nutritional R&D team has developed a new strain of yeast probiotic, Saccharomyces boulardii Bld-3 (S. boulardii Bld-3), and an innovative production technology for the new product. The patented yeast probiotic is designed to support digestive and immune health in children and adults.

Angel Yeast announced it has developed a new strain of yeast probiotic, Saccharomyces boulardii Bld-3 (S. boulardii Bld-3) to support digestive and immune health in children and adults.

"Saccharomyces boulardii (S. boulardii) is a kind of probiotic that is a well-recognised nutritional intervention for digestive comfort. The new strain of yeast probiotic developed by Angel Nutrition & Health Technical Center, S. boulardii Bld-3, is another ground-breaking addition to the S. boulardii family that has been shown to help maintain digestive comfort and is beneficial to intestinal health in the long term," said the CTO of Angel Nutritech, established in 1992 by Angel Yeast focusing on human nutrition & health to develop and supply featured finished products to global human care industries.

COVID-19 has prompted more people to pay attention to their health and an increased focus on precautionary measures and healthcare products that prevent diseases and support their immune systems. On Google Trends, the search queries "gut health" and "probiotic" have seen several spikes in recent years. For gastrointestinal healthcare, keyword searches related to probiotics also climbed to a record high this year, signaling increased recognition of its robust ability to restore and maintain a healthy digestive system for humans.

The use of S. boulardii has been widely used in digestive-health products for decades, and its role in gastrointestinal health is well documented in the scientific literature. A study published in the Chinese Journal of Pediatrics concludes that certain types of probiotics can help maintain digestive comfort. Among them, Lactobacillus rhamnosus GG and S. boulardii are among the most widely used probiotics for digestive health.

Unlike Lactobacillus probiotics, Angel's S. boulardii Bld-3 is developed using the low-temperature fluidized bed process. The company's unique protection technology allows it to quickly form a dense yeast shell that encloses active yeast probiotics entrapped inside. This process strengthens the yeast's resistance to gastric acid and bile salts, enabling it to be applied in a wide variety of end probiotic products.

Angel's S. boulardii Bld-3 is a suitable ingredient for wide-ranging probiotic dietary supplements. Thanks to the larger size of yeast probiotics, which is ten times as big as that of Lactobacillus probiotics, they are more likely to form a space-occupying effect in the intestinal tract and are resistant to antibiotics.

One of the world's largest suppliers of yeast derivatives, Angel Yeast has over three decades of experience in the development and production of yeast products. In addition to S. boulardii Bld-3, Angel Yeast also produces Saccharomyces cerevisiae probiotic and other extensive ranges of functional yeast ingredients, with several new products in the pipeline including Kluyveromyces marxianus. At present, probiotic products produced by Angel Yeasthave been sold to Europe and North America.

About Angel Yeast

Founded in 1986, Angel Yeast Co., Ltd specializes in the production of yeast and yeast derivatives. Its product range includes baker's yeast and ingredients, Chinese dim sum solutions, yeast extract-savory, human health, animal nutrition, plant care, brewing & biofuels, microbial nutrition, and enzymes. At present, Angel Yeast has 11 international advanced production bases in China, Egypt, and Russia, and provides products and services for more than 150 countries and regions globally.